National Institutes of Health
scientists have identified a new type of dementia and have named it LATE or
Limbic-predominant Age-related TDP-43 Encephalopathy as reported April 30,
2019, in the journal Brain.
LATE is an under-recognized
condition and the “oldest-old” (80 years and older) are at greatest risk of
developing it.
LATE affects multiple areas of
cognition, ultimately impairing activities of daily life. It mimics the
clinical features of Alzheimer’s disease, but is more slowly progressing. But,
LATE combined with Alzheimer’s causes a more rapid decline than either
condition alone would.
Now there is rising
appreciation that a variety of diseases and disease processes contribute to
dementia. Each condition appears differently when a brain sample is examined at
autopsy. However, it has been increasingly clear that in advanced age, a large
number of people had symptoms of dementia without the telltale signs in their
brain at autopsy. Emerging research seems to indicate that the protein TDP-43
may contribute to that phenomenon.
The autopsy diagnosis has been
suggested in three stages, according to where in the brain TDP-43 is detected:
· Stage
1: amygdala only
· Stage
2: amygdala and hippocampus
· Stage
3: amygdala, hippocampus and middle frontal gyrus
TDP-43 (transactive response
DNA binding protein of 43 kDa) is a protein that normally helps to regulate
gene expression in the brain and other tissues. Recent research has shown
misfolded TDP-43 protein as being very common in older adults. Around 25% of
people over 85 years of age have enough misfolded TDP-43 protein to affect
their memory and/or thinking abilities.
Unusually misfolded TDP-43 has
a causative role in most cases of amyotrophic lateral sclerosis and
frontotemporal lobar degeneration. TDP-43 pathology is also commonly associated
with hippocampal sclerosis. The hippocampal region of brain plays an important
role in memory and learning. Therefore, cognitive impairment as the symptoms of
hippocampal sclerosis may appear to be very similar to the effects of
Alzheimer’s disease.
(Source: NIH, April 30, 2019)
Dr KK Aggarwal
Padma Shri Awardee
President Elect Confederation of
Medical Associations in Asia and Oceania
(CMAAO)
Group Editor-in-Chief IJCP Publications
President Heart Care Foundation of
India
Past National President
IMA
No comments:
Post a Comment